154 related articles for article (PubMed ID: 13918323)
1. The treatment of head and neck cancer with the continuous arterial infusion of methotrexate and the intermittent intramuscular administration of citrovorum factor.
SULLIVAN RD; DALY JF
Trans Am Laryngol Assoc; 1961; 82():54-72. PubMed ID: 13918323
[No Abstract] [Full Text] [Related]
2. Continuous arterial infusion of methotrexate with intermittent, intramuscular citrovorum factor therapy in head and neck cancer.
SULLIVAN RD
Trans Pac Coast Otoophthalmol Soc Annu Meet; 1961; 42():29-42. PubMed ID: 13918329
[No Abstract] [Full Text] [Related]
3. Continuous intraarterial methotrexate with simultaneous, intermittent, intramuscular citrovorum factor herapy in carcinoma of the cervix.
SULLIVAN RD; WOOD AM; CLIFFORD P; DUFF JK; TRUSSEL R; NARY DK; BURCHENAL JH
Cancer Chemother Rep; 1960 Jul; 8():1-6. PubMed ID: 13835652
[No Abstract] [Full Text] [Related]
4. Antimetabolite-metabolite cancer chemotherapy using continuous intra-arterial methotrexate with intermittent intramuscular citrovorum factor. Method of therapy.
DUFF JK; SULLIVAN RD; MILLER E; ULM AH; CLARKSON BD; CLIFFORD P
Cancer; 1961; 14():744-52. PubMed ID: 13724783
[No Abstract] [Full Text] [Related]
5. Antimetabolite-metabolite combination cancer chemotherapy. Effects of intraarterial methotrexate-intramuscular Citrovorum factor therapy in human cancer.
SULLIVAN RD; MILLER E; SIKES MP
Cancer; 1959; 12():1248-62. PubMed ID: 13835650
[No Abstract] [Full Text] [Related]
6. Carcinoma of the cervix treated with continuous intra-arterial methotrexate and intermittent intramuscular leucovorin.
TRUSSELL RR; MITFORD-BARBERTON GD
Lancet; 1961 May; 1(7184):971-2. PubMed ID: 13778294
[No Abstract] [Full Text] [Related]
7. Cancer therapy by intra-arterial methotrexate infusion. Protection of mucous membranes by topically applied citrovorum factor with hyaluronidase.
STOVNER J; ENGSETH A; BRENNHOVD I
Cancer Chemother Rep; 1962 Aug; 21():147-8. PubMed ID: 13917570
[No Abstract] [Full Text] [Related]
8. Increase of urinary citrovorum factor activity in patients receiving methotrexate (amethopterin).
LI MC; NIXON WE; FREEMAN MV
Proc Soc Exp Biol Med; 1958 Jan; 97(1):29-32. PubMed ID: 13518171
[No Abstract] [Full Text] [Related]
9. The use of methotrexate orally in treatment of squamous cancers of the head and neck.
HUSEBY RA; DOWNING V
Cancer Chemother Rep; 1962 Feb; 16():511-4. PubMed ID: 14036458
[No Abstract] [Full Text] [Related]
10. The treatment of carcinoma of the cervix by continuous intra-arterial methotrexate and by intermittent intramuscular leucovorin.
TRUSSELL RR
Proc R Soc Med; 1962 Sep; 55(9):759-60. PubMed ID: 13994400
[No Abstract] [Full Text] [Related]
11. CONTINUOUS INTRA-ARTERIAL INFUSION OF METHOTREXATE FOR RECURRENT SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK.
ACQUARELLI MJ; FEDER RJ; GORDON HE
Am Surg; 1964 Jul; 30():423-30. PubMed ID: 14179036
[No Abstract] [Full Text] [Related]
12. Folic acid antagonists in therapy of leukemia and tumors; problem of resistance and relations with the citrovorum factor.
PAOLINO W
Minerva Med; 1952 Jun; 43(48):1296-1300. PubMed ID: 12982647
[No Abstract] [Full Text] [Related]
13. Cancer chemotherapy by arterial infusion.
BENSON JW; KIEHN CL; HOLDEN WD
Arch Surg; 1963 Jul; 87():125-44. PubMed ID: 13967518
[No Abstract] [Full Text] [Related]
14. The formation of citrovorum factor in the developing chick egg and the effect of injecting folic acid antagonists.
SWENDSEID ME; JACKSON R; BENSON EM
Arch Biochem Biophys; 1958 Nov; 78(1):221-6. PubMed ID: 13595920
[No Abstract] [Full Text] [Related]
15. Effects of folinic acid on amethopterin-induced inhibition of the Ehrlich ascites carcinoma.
SARTORELLI AC; UPCHURCH HF; BOOTH BA
Cancer Res; 1962 Jan; 22():102-6. PubMed ID: 14497283
[No Abstract] [Full Text] [Related]
16. Citrovorum factor; nutritional aspects, associations with leukemia and anemia.
BAUMANN CA
J Am Diet Assoc; 1953 Jun; 29(6):548-54. PubMed ID: 13061228
[No Abstract] [Full Text] [Related]
17. A METHOD OF CONTINUOUS INTRAVASCULAR INFUSION OF METHOTREXATE IN THE PALLIATIVE TREATMENT OF MALIGNANT DISEASE IN PATIENTS.
MILLER BJ; TALSANIA SJ; CONNOLLY JM
J Germantown Hosp; 1963 Aug; 4():61-71. PubMed ID: 14044989
[No Abstract] [Full Text] [Related]
18. The pharmacology and clinical use of methotrexate.
Jolivet J; Cowan KH; Curt GA; Clendeninn NJ; Chabner BA
N Engl J Med; 1983 Nov; 309(18):1094-104. PubMed ID: 6353235
[No Abstract] [Full Text] [Related]
19. THE EFFECTS UPON HAEMOPOIESIS OF PROLONGED INTRAARTERIAL INFUSIONS OF METHOTREXATE COMBINED WITH THE INTERMITTENT ADMINISTRATION OF FOLINIC ACID: WITH OBSERVATIONS ON THE PLASMA LEVELS AND URINARY EXCRETION OF METHOTREXATE.
ROSE DP; BOND MR; EVANS C
Br J Cancer; 1965 Mar; 19(1):126-33. PubMed ID: 14284373
[No Abstract] [Full Text] [Related]
20. Further observations on the effect of aminopterin, a-methopterin and citrovorum factor on the growth of transplantable avian lymphoid tumours.
CHUBB LG; LAURSEN AL
Br J Pharmacol Chemother; 1954 Dec; 9(4):419-22. PubMed ID: 13219264
[No Abstract] [Full Text] [Related]
[Next] [New Search]
